These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34327391)

  • 1. Validation of the IMPROVE bleeding risk score in Chinese medical patients during hospitalization: Findings from the dissolve-2 study.
    Zhang Z; Zhai Z; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Wang C;
    Lancet Reg Health West Pac; 2020 Nov; 4():100054. PubMed ID: 34327391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the IMPROVE bleeding risk assessment model in surgical patients: Results from the DissolVE-2 Study.
    Zhang Z; Zhen K; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Shen D; Du J; Cai C; Zhai Z; Wang C;
    Thromb Res; 2023 Mar; 223():69-77. PubMed ID: 36708692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
    Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
    Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
    Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
    J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: A real-world study in Chinese patients.
    Zhang Z; Lei J; Zhai Z; Yang Y; Wan J; Xie W; Wang C
    Clin Respir J; 2019 Mar; 13(3):139-147. PubMed ID: 30661286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score.
    Villiger R; Julliard P; Darbellay Farhoumand P; Choffat D; Tritschler T; Stalder O; Rossel JB; Aujesky D; Méan M; Baumgartner C
    Thromb Res; 2023 Oct; 230():37-44. PubMed ID: 37634309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population.
    Wilkinson KS; Sparks AD; Gergi M; Repp AB; Al-Samkari H; Thomas R; Roetker NS; Zakai NA
    Res Pract Thromb Haemost; 2024 May; 8(4):102441. PubMed ID: 38953050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study.
    Zhai Z; Kan Q; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Zhang Z; Wang C;
    Chest; 2019 Jan; 155(1):114-122. PubMed ID: 30300652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria.
    Chamoun N; Ramia E; Lteif C; Salameh P; Zantout H; Ghanem G; Chatila R
    Curr Med Res Opin; 2019 Mar; 35(3):427-433. PubMed ID: 30221541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
    Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
    Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
    Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
    Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
    JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a retrospective single-center cohort study in Japan.
    Arakaki D; Iwata M; Terasawa T
    Thromb J; 2024 Mar; 22(1):31. PubMed ID: 38549086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.
    Woller SC; Stevens SM; Jones JP; Lloyd JF; Evans RS; Aston VT; Elliott CG
    Am J Med; 2011 Oct; 124(10):947-954.e2. PubMed ID: 21962315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.
    Beshir SA; Aziz Z; Yap LB; Chee KH; Lo YL
    J Clin Pharm Ther; 2018 Apr; 43(2):209-219. PubMed ID: 29030869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
    Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
    Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1).
    Jarrah M; Hammoudeh A; Okkeh O; Khader Y; Gharaibeh S; Nasser L; Rasheed A; Al-Hindi A; Mohealdeen M; Kharabsheh H; Abunimeh H; Hijjih E; Tashman L; Omar D; Kufoof N;
    Anatol J Cardiol; 2017 Jun; 17(6):445-451. PubMed ID: 28344216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.